C. Mavragani

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies

Maryam Dastmalchi, Cecilia Grundtman, Helene Alexanderson et al. · Annals of the Rheumatic Diseases · 2008 · 256 citations

Medicine, Immunology, Internal Medicine +17

Recurrent pregnancy loss and autoantibody profile in autoimmune diseases

C. Mavragani, John P. A. Ioannidis, Athanasios G. Tzioufas et al. · Lara D. Veeken · 1999 · 36 citations · Full text

Life Sciences, Immunology, Obstetrics +17

Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients

Katerina Laskari, Maria G. Tektonidou, Christina Katsiari et al. · Seminars in Arthritis and Rheumatism · 2020 · 29 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations

C. Mavragani, Stamatina Danielides, PG Vlachoyiannopoulos et al. · Lupus · 2009 · 18 citations

Life Sciences, Endocrinology, Immunology +16

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma

Stamatina Danielides, C. Mavragani, Ioannis Katsakoulas et al. · Scandinavian Journal of Rheumatology · 2011 · 12 citations

Life Sciences, Immunology, Pathology +15